Navigation Sciences announced today that it closed the initial $3 million tranche of a $5 million Series B financing round. Brookline, Massachusetts-based Navigation Sciences develops the NaviSci system for use in precision surgery for early-stage lung cancer. The company designed the system to provide surgeons with real-time “GPS” guidance during minimally invasive surgery. It enables […]
Oncology
Procept BioRobotics wins FDA IDE for Aquablation prostate cancer therapy
Procept BioRobotics (Nasdaq:PRCT) announced today that it received FDA investigational device exemption (IDE) for its Aquablation therapy. The IDE allows Procept to initiate a single-arm feasibility study for the Aquablation prostate cancer therapy in the U.S. Data generated from the study could support future research and regulatory applications in the U.S. The company plans to […]
Philips launches utrasound tech to boost cancer diagnostics
Philips recently announced that it has incorporated a super-resolution contrast-enhanced ultrasound (CEUS) application into its EPIQ Elite ultrasound system. The addition of microvascular imaging super-resolution CEUS enables three times better spatial resolution than previous models, according to Philips. It could potentially improve the diagnostic accuracy for assessing lesion blood flow in cancer patients. Understanding blood […]
Quantum Surgical wins CE mark to treat lung tumors with its surgical robot
Quantum Surgical recently announced that it received expanded CE mark approval for the use of its Epione surgical robotic platform. The Montpellier, France–based company won expanded indications for Epione in the treatment of lung tumors. Epione, the company’s flagship product, offers curative treatment for cancers. Quantum Surgical designed it to plan, target, deliver and confirm […]
Boston Scientific wins expanded FDA clearance for Visual Ice cryoablation system
Boston Scientific announced today that it received expanded FDA 510(k) clearance for its Visual Ice cryoablation system. News of the regulatory nod comes just weeks after the FDA approved the company’s POLARx cryoablation system for treating paroxysmal AFib. Clearance grants the device an indication expansion for use in the treatment of pain associated with tumors. […]
First cancer patient treated with RefleXion biology-guided radiotherapy
RefleXion Medical announced today that the first patient completed treatment with Scintix biology-guided radiotherapy on its X1 machine. Scintix treats early- and late-stage cancers using the individual biology of each tumor to drive its own treatment. It allows each cancer’s unique biology to autonomously determine how much radiation to deliver. This occurs on a second-by-second […]
Imidex wins FDA clearance for AI-powered X-ray software
Imidex announced that it received FDA 510(k) clearance for its flagship, AI-powered VisiRad XR software product. VisiRad XR analyzes chest X-rays and highlights possible lung nodules and masses. It employs state-of-the-art machine learning techniques developed using curated training data from around the world. According to Imidex, the software offers clinicians a closer look at often-overlooked […]
Illumina says SEC is investigating Grail acquisition
Add a U.S. Securities and Exchange Commission investigation to the list of problems that Illumina has faced since it acquired Grail for $8 billion in 2021. Illumina disclosed the investigation in its 10-Q filed with the SEC on Aug. 10: “In July 2023, we were informed that the staff of the SEC was conducting an […]
Siemens Healthineers, SSM ink deal to improve health equity
SSM Health and Siemens Healthineers announced today that they entered into a 10-year strategic partnership focused on health equity. The companies aim to expand access to high-quality care and aid in training the next generation of healthcare workers. Siemens Healthineers says the agreement marks its largest geographic strategic partnership to date. SSM Health, a fully […]
DermaSensor reports positive results for skin cancer detection device across multiple skin tones
DermaSensor today announced promising results from a sub-analysis study focusing on skin cancer detection across different skin tones. The sub-analysis came from the company’s DERM-SUCCESS study, which previously demonstrated positive results. It focused on the company’s handheld elastic scattering spectroscopy (ESS) device performance across Fitzpatrick skin types. This skin tone scale classifies skin coloring and […]
Accuray gets FDA nod for breast cancer treatment on Radixact system
Accuray (Nasdaq:ARAY) announced that the FDA granted 510(k) clearance to its VitalHold breast package on the Radixact system. The company also says it expects the treatment option to become available in Europe. VitalHold facilitates deep inspiration breath hold (DIBH) treatments. It uses the Radixact System’s fixed beam angle delivery mode (TomoDirect) and fully integrated, automated […]
